Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Octagon Pharmaceutical Co., Ltd. is a leading Chinese manufacturer of anticoagulant active pharmaceutical ingredients (APIs) and a key subsidiary of Yantai Dongcheng Pharmaceutical Group. The company is globally recognized for its large-scale production of Heparin Sodium and Enoxaparin Sodium, maintaining certifications from the US FDA, EU GMP, and EDQM. Based in Yantai, Shandong, the firm operates as a critical node in the international supply chain for cardiovascular and hematological treatments. Beyond its core heparin business, Shandong Octagon produces various biochemical products including Chondroitin Sulfate and Cytochrome C. Its commitment to high-quality standards has established it as a preferred partner for major pharmaceutical firms worldwide. The company's facilities are designed to meet rigorous international regulatory requirements, ensuring the safety and efficacy of its biological extracts.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shandong Octagon.